Guided Therapeutics (GTHP) FCF Margin Growth (5y) (2016 - 2025)
Guided Therapeutics (GTHP) FCF Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,468.00 |
| Sep 30, 2025 | 30,327.00 |
| Dec 31, 2024 | -3.19 Mn |
| Mar 31, 2024 | -63,333.00 |
| Dec 31, 2023 | -30,952.00 |
| Jun 30, 2023 | 161,705.00 |
| Mar 31, 2023 | 738,182.00 |
| Sep 30, 2022 | -2.06 Mn |
| Jun 30, 2022 | -746,943.00 |
| Mar 31, 2022 | -192,667.00 |
| Dec 31, 2021 | 16,313.00 |
| Sep 30, 2021 | -379,474.00 |
| Dec 31, 2020 | -125,733.00 |
| Sep 30, 2020 | -61,494.00 |
| Sep 30, 2019 | -2.36 Mn |
| Jun 30, 2019 | -1.90 Mn |
| Mar 31, 2019 | -101,228.00 |
| Dec 31, 2018 | -80,348.00 |
| Sep 30, 2018 | -2.50 Mn |
| Mar 31, 2018 | -958,952.00 |